Displaying 701–725 of 796 results for Packaging
In a recent talk, Wal-Mart’s manager of RFID strategies sounded upbeat about his firm’s progress in end-to-end RFID shipping. But the retail giant’s not as far along as people think, says ARC Advisory Group’s Steve Banker.
Combating Counterfeit Drugs: Government and industry have failed to confront this white elephant jointly. Concerted efforts, focused on risk, will be essential, asserts Carl Nielsen, FDA's former director of Import Operations and Policy, in this exclusive commentary.
The software industry had Linux. What will RFID users have to open up their systems? It's time to put enabling technology in the hands of the masses, says RFID Alliance Lab's Daniel Deavours.
FDA Bar Code Rule: What packaging levels does the rule apply to? Should different coding be used for product and packaging? Bert Moore of AIM Global clears up the confusion.
FDAs recent guidance on pharmacogenomics reduces manufacturers risks in evaluating genomic data. Will it spur development of more targeted therapies?
Pharmaceutical processing & engineering: The Kaiser Family Foundation recently polled 1,200 people regarding their views on drugs and the pharmaceutical industry, and the data revealed a fair amount of negativity toward drug manufacturers.
While one name Rudy may draw much of the attention at Aprils Interphex 2005 Conference and Exhibition, it may be the depth and quality of exhibitors and presenters that eventually steals the show at the Jacob K. Javits Convention Center, April 26-28.
Careful validation and quality assurance work, and close collaboration with vendors, was a “win-win” for all who helped develop Bayer Biological Products’ cold chain solutions.
After 32 years with Eli Lilly and over 23 years heading up that companys process analytics effort, Rick Cooley will start a new position on March 1, as manager of the Process Analytics Center of Excellence for the chromatography equipment vendor, Dionex Corp.
Is your job safe? You can read the writing on the wall if you know the right questions to ask. Plus, 10 signs your company may be downsizing soon.
Even before Peter Rost testified in favor of reimportation before a Senate committee, Pfizer SVP Chuck Hardwick had fired off this letter to Senate Committee Chairman Enzi, arguing that reimportation endangers the U.S. drug supply and the public.
The latest reports by ARC, In-Stat and ABI give RFID a “C” (as in Costly) for the present, but an “A” for market potential.
Before they can embrace RFID and integrate it into their enterprise IT systems, pharmaceutical manufacturers must grapple with several key issues, including how to justify the ROI. In this exclusive interview, SAP's Jim Sabogal discusses problems firms are having with RFID, and strategies that ...
Remember isotopes from Chemistry 101? As used in Stable Isotope Analysis, they offer a surefire way to authenticate APIs and products without additives. John P. Jasper, who helped pioneer the technology, discusses what it can do and where it's heading.
Drug Pedigree RFID tags can never take off unless HF (13.56 MHz) becomes the norm; FDA appears to realize this, and is leaning toward HF at the unit level. Bert Moore of AIM Global discusses this situation.
Stewardship concerns led Baxter Healthcare to create EthicsKit, an online guide to building an ethics program from scratch. Integrity led the company to share it.
If you're not sure what a team is or what it can accomplish, you need to know the seven deadly sins that can destroy your team before it even gets to the huddle.
In my view, manufacturers who use tamper-evident packaging do it primarily as a compliance measure (as with OTC pharmaceuticals), as a show of good faith to consumers, and/or as a cost-effective way to reduce jury awards should product tampering occur.
Axess Technologies director Richard Jotcham outlines the fundamentals security in authentication and tracking technologies.
There is no "silver bullet" for protecting the pharmaceutical supply chain. In this article, Susanne Hasselman, director of Axess Technologies, outlines a four-step strategy to improve brand protection.
Middleware offers a way to integrate RFID technology, and the copious data it generates, with pharmaceutical manufacturers' current processes and systems.